High Tide (HITI)
(Delayed Data from NSDQ)
$2.61 USD
+0.07 (2.76%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $2.59 -0.02 (-0.77%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Brokerage Reports
0 items in cart
High Tide Inc. [HITI]
Reports for Purchase
Showing records 1 - 20 ( 82 total )
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
1Q24 Beat, Executing and Generating FCF, Reiterate Buy $4.50 PT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
1Q24 Preview, Seasonally Tempered, Store Growth LT Thesis Intact
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Weekly ReHash: Vape Industry Snapshot, Rapidly Growing Cannabis Sub-Category
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Weekly ReHash: Cash Flow Key and Rescheduling Look
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
FY23 Solid Consistent Execution, FCF to Drive ''24 Store Growth, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
4Q23 Preview, Retail Leader to Cheap on Strong Operations, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
2024 Cannabis Industry Outlook: Resetting and Anticipating Regulatory Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Completes Debt Restructuring of $8.9M to Accelerate Store Growth
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
3Q23 + FCF Execution U.S. THC Optionality Not Priced In, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S